本报讯 记者董宇虹报道 6月17日，记者从昆明市市场监督管理局获悉，市市场监管局积极引导医疗器械经营企业创新发展，云南省医药有限公司获批医疗器械多仓协同经营许可，成为云南首家获得医疗器械多仓协同业务资质的企业。
市市场监管局全程为云南省医药有限公司提供指导与支持，快速完成申请受理、材料审查和许可变更办理等工作。云南省医药有限公司构建“五统一”管理体系，统一质量管理、统一信息系统、统一指导监督、统一调度指挥和统一作业标准，有效整合集团仓储运输资源，实施医疗器械多仓协同管理，实现全流程可追溯。同时，将多仓协同业务纳入数字化监管体系，可向监管部门传输数据，实现透明化、智能化监管。
下一步，市市场监管局将积极引导大型医疗器械经营企业参与多仓协同物流管理模式，进一步整合仓储和运输资源，降低产品储运风险，提高配送效率。同时，规范医疗器械多仓协同经营行为，及时防控风险，推动医疗器械产业创新发展。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.